[Skip to Content]
[Skip to Content Landing]
December 3, 2014

Zirconium Cyclosilicate for Treatment of Hyperkalemia

Author Affiliations
  • 1Veterans Administration Medical Center, Iowa City, Iowa
  • 2Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2014;312(21):2217-2218. doi:10.1001/jama.2014.15736

Hyperkalemia is a commonly encountered clinical problem and has been reported in up to 10% of hospitalized patients, with 10% to 38% of those episodes associated with medications that block the renin-angiotensin-aldosterone system (RAAS).1 Mortality has been shown to be increased in patients with hyperkalemia even after accounting for other comorbidities.2

First Page Preview View Large
First page PDF preview
First page PDF preview